Forte biosciences, inc.FBRX.US Overview

US StockHealthcare

(No presentation for FBRX)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

FBRX Overall Performance

FBRX AI Analysis & Strategy

FBRX Recent Performance

1.35%

Forte biosciences, inc.

0.29%

Avg of Sector

0.14%

S&P500

FBRX PowerScanner

FBRX Key Information

FBRX Valuation Metrics

FBRX Earnings Table

FBRX Profile

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.